Skip to main content
ILDONG HOLDINGS CO.,LTD  logo

ILDONG HOLDINGS CO.,LTD — Investor Relations & Filings

Ticker · 000230 ISIN · KR7000230003 KO Manufacturing
Filings indexed 368 across all filing types
Latest filing 2025-02-07 Earnings Release
Country KR South Korea
Listing KO 000230

About ILDONG HOLDINGS CO.,LTD

https://www.ildongholdings.com

ILDONG HOLDINGS CO.,LTD. is a holding company that manages a diversified healthcare group. Its primary subsidiary, Ildong Pharmaceutical, develops, manufactures, and supplies a broad portfolio of pharmaceutical products, including over-the-counter drugs, vitamins, and antibiotics. The pharmaceutical division maintains a robust R&D pipeline focused on treating metabolic disorders, gastrointestinal diseases, and degenerative conditions. Other key subsidiaries include ILDONG BIOSCIENCE, a specialist in probiotics and functional health foods, and Ildong Healthcare, which provides healthy-lifestyle products such as water ionization units. The group collectively aims to enhance human health through its diverse offerings in pharmaceuticals, bioscience, and consumer healthcare.

Recent filings

Filing Released Lang Actions
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release Classification · 95% confidence The document is a regulatory filing from Ildong Holdings regarding a significant change in sales or profit/loss structure (30% or more). It provides preliminary financial results (revenue, operating profit, net income) for the current and previous fiscal years. This type of disclosure is a standard regulatory requirement in the Korean market (DART system) for reporting material changes in financial performance before the final audit report is published. It fits the 'Earnings Release' (ER) category as it provides key financial highlights and performance metrics. FY 2024
2025-02-07 Korean
주주총회소집결의
AGM Information Classification · 99% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Ildong Holdings. It outlines the agenda for the upcoming Annual General Meeting, including the approval of financial statements, election of directors and auditors, and remuneration limits. This type of document is sent to shareholders to provide information and request their votes for the meeting, which fits the definition of a Proxy Solicitation & Information Statement.
2025-02-07 Korean
결산실적공시예고(안내공시)
Report Publication Announcement Classification · 100% confidence The document is a short announcement (472 characters) from Ildong Holdings notifying the market of the upcoming date for the release of their annual financial results (2025-02-07). It does not contain the actual financial results, but rather serves as a notice of publication. According to the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA).
2025-02-04 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Services Commission and the Korea Exchange. This type of filing is a mandatory regulatory disclosure in South Korea (often referred to as the '5% rule' filing) used to notify the market when a person or entity acquires a significant stake in a company. Based on the provided categories, this fits the 'Major Shareholding Notification' (MRQ) classification.
2025-01-20 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount Classification · 95% confidence The document is a short regulatory announcement from Il-dong Holdings regarding the setting of a record date and shareholder register closure period for the purpose of holding an upcoming Annual General Meeting (AGM). Since it is a brief regulatory notice announcing a procedural step rather than the AGM materials themselves or a full report, it falls under the category of general regulatory announcements.
2024-12-16 Korean
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for Ildong Holdings, covering the period from January 1, 2024, to September 30, 2024. It contains detailed financial statements, management discussion, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-11-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.